Collins I - Search Results

1

DNA conformation, topology, and the regulation of c-myc expression.

Levens D, Duncan RC, Tomonaga T, Michelotti GA, Collins I, Davis-Smyth T, Zheng T, Michelotti EF. Levens D, et al. Among authors: collins i. Curr Top Microbiol Immunol. 1997;224:33-46. doi: 10.1007/978-3-642-60801-8_3. Curr Top Microbiol Immunol. 1997. PMID: 9308226 Review. No abstract available.

2

TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression.

Weber A, Liu J, Collins I, Levens D. Weber A, et al. Among authors: collins i. Mol Cell Biol. 2005 Jan;25(1):147-61. doi: 10.1128/MCB.25.1.147-161.2005. Mol Cell Biol. 2005. PMID: 15601838 Free PMC article.

3

A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-strand-binding protein FBP.

Duncan R, Collins I, Tomonaga T, Zhang T, Levens D. Duncan R, et al. Among authors: collins i. Mol Cell Biol. 1996 May;16(5):2274-82. doi: 10.1128/MCB.16.5.2274. Mol Cell Biol. 1996. PMID: 8628294 Free PMC article.

4

Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression.

He L, Liu J, Collins I, Sanford S, O'Connell B, Benham CJ, Levens D. He L, et al. Among authors: collins i. EMBO J. 2000 Mar 1;19(5):1034-44. doi: 10.1093/emboj/19.5.1034. EMBO J. 2000. PMID: 10698944 Free PMC article.

5

Transcriptional consequences of topoisomerase inhibition.

Collins I, Weber A, Levens D. Collins I, et al. Mol Cell Biol. 2001 Dec;21(24):8437-51. doi: 10.1128/MCB.21.24.8437-8451.2001. Mol Cell Biol. 2001. PMID: 11713279 Free PMC article.

6

The FBP interacting repressor targets TFIIH to inhibit activated transcription.

Liu J, He L, Collins I, Ge H, Libutti D, Li J, Egly JM, Levens D. Liu J, et al. Among authors: collins i. Mol Cell. 2000 Feb;5(2):331-41. doi: 10.1016/s1097-2765(00)80428-1. Mol Cell. 2000. PMID: 10882074 Free article.

7

NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter.

Huth JR, Yu L, Collins I, Mack J, Mendoza R, Isaac B, Braddock DT, Muchmore SW, Comess KM, Fesik SW, Clore GM, Levens D, Hajduk PJ. Huth JR, et al. Among authors: collins i. J Med Chem. 2004 Sep 23;47(20):4851-7. doi: 10.1021/jm0497803. J Med Chem. 2004. PMID: 15369388

8

Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis.

Nadella S, Burks J, Huber M, Wang J, Cao H, Kallakury B, Tucker RD, Boca SM, Jermusyck A, Collins I, Vietsch EE, Pierobon M, Hodge KA, Cui W, Amundadottir LT, Petricoin E 3rd, Shivapurkar N, Smith JP. Nadella S, et al. Among authors: collins i. Pancreas. 2019 Aug;48(7):894-903. doi: 10.1097/MPA.0000000000001360. Pancreas. 2019. PMID: 31268978

9

Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment.

Smith JL, Freebern WJ, Collins I, De Siervi A, Montano I, Haggerty CM, McNutt MC, Butscher WG, Dzekunova I, Petersen DW, Kawasaki E, Merchant JL, Gardner K. Smith JL, et al. Among authors: collins i. Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11554-9. doi: 10.1073/pnas.0402156101. Epub 2004 Jul 30. Proc Natl Acad Sci U S A. 2004. PMID: 15286281 Free PMC article.

10

Pharmacologic profiling of transcriptional targets deciphers promoter logic.

Freebern WJ, Haggerty CM, Montano I, McNutt MC, Collins I, Graham A, Chandramouli GV, Stewart DH, Biebuyck HA, Taub DD, Gardner K. Freebern WJ, et al. Among authors: collins i. Pharmacogenomics J. 2005;5(5):305-23. doi: 10.1038/sj.tpj.6500325. Pharmacogenomics J. 2005. PMID: 16044165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page